Chemkart India Limited has issued a revised update on its Rs. 1.48 Cr investment in its subsidiary, Easy Raw Materials Private Limited, through a Rights Issue.

The key clarification is that this investment's primary purpose is to fund the commissioning of a manufacturing unit for the subsidiary.

Easy Raw Materials, incorporated in 2020 and dealing in pharma and nutritional supplements, reported a NIL turnover and a loss of 12.68 Lakhs as of March 2025. Chemkart maintains its 99% shareholding in the subsidiary.

This strategic investment aims to enhance the subsidiary's operational capabilities.